Proliferation kinetics and prognosis in gastric cancer after resection

European Journal of Cancer

Volumn 37, Issue 13, 2001, Pages 1635-1641

  Sendler, A ^a   Gilbertz, K P ^b   Becker, I ^a   Mueller, J ^c   Berger, U ^a   Fink, U ^a   Van Beuningen, D ^b   Siewert, J R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Sanitatsakademie der Bundeswehr   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bromodeoxyuridine; Cell kinetics; Gastric neoplasms; Ki 67; PCNA; Prognostic factors; Proliferation

Indexed keywords

BROXURIDINE; CELL NUCLEUS ANTIGEN; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; FLOW CYTOMETRY; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; TREATMENT OUTCOME; TUMOR GROWTH;

EID: 0034892292     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00186-1     Document Type: Article

References (33)

1. Significance of cell proliferation measurement in gastric cancer
2. Stomach carcinoma
3. Bromodeoxyuridine: A diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis
4. Monoclonal antibody to 5-bromo- and 5-iodo-deoxyuridine: A new reagent for detection of DNA replication
5. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample
6. The current management of gastric cancer
7. Multidisciplinary approach to esophageal and gastric cancer
8. Gastric tumors
9. Intra-tumoural heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer
10. In vivo cell kinetic measurements in human oesophageal cancer: What can be learned from multiple biopsies?
11. Nonparametric estimation form incomplete observations
12. Regression models and life-tables
13. Relevant prognostic factors in gastric cancer
14. Prognosefaktoren beim Magencarcinom
15. Bromodeoxyuridine for cell kinetic investigations in humans
16. Proliferative activity of early gastric cancer measured by in vitro and in vivo bromodeoxyuridine labeling
17. Proliferative activity and malignancy in human gastric cancers. Significance of the proliferation rate and its clinical application
18. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma: An attempt at a histo-clinical classification
19. Can measurements of potential doubling time (Tpot) be compared between laboratories? A quality control study
20. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration bromodeoxyuridine on human gastric cancers
21. Assessment of tumor cell kinetics by monoclonal antibody Ki-67
22. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma
23. Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer
24. Proliferative rate by S-phase measurement may affect cure of breast carcinoma
25. Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression, and flow cytometric analysis. Prognostic significance in acute nonlymphoblastic leukemia
26. Mutations of mitotic checkpoint genes in human cancers
27. Evidence for quiescent S- and G2-phase cells in human colorectal carcinomas: A flow cytometric study with the Ki-67 antibody
28. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: A multicenter analysis
29. Is a high rate of cell proliferation carcinogenic in itself?